These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7706123)

  • 1. CJ-12,371 and CJ-12,372, two novel DNA gyrase inhibitors. Fermentation,isolation, structural elucidation and biological activities.
    Sakemi S; Inagaki T; Kaneda K; Hirai H; Iwata E; Sakakibara T; Yamauchi Y; Norcia M; Wondrack LM; Sutcliffe JA
    J Antibiot (Tokyo); 1995 Feb; 48(2):134-42. PubMed ID: 7706123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CJ-12,373, a novel topoisomerase II inhibitor: fermentation, isolation, structure elucidation and biological activities.
    Inagaki T; Kaneda K; Suzuki Y; Hirai H; Nomura E; Sakakibara T; Yamauchi Y; Huang LH; Norcia M; Wondrack LM; Sutcliffe JA; Kojima N
    J Antibiot (Tokyo); 1998 Feb; 51(2):112-6. PubMed ID: 9544930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New pyrrolizidinone antibiotics CJ-16,264 and CJ-16,367.
    Sugie Y; Hirai H; Kachi-Tonai H; Kim YJ; Kojima Y; Shiomi Y; Sugiura A; Sugiura A; Suzuki Y; Yoshikawa N; Brennan L; Duignan J; Huang LH; Sutcliffe J; Kojima N
    J Antibiot (Tokyo); 2001 Nov; 54(11):917-25. PubMed ID: 11827034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CJ-21,058, a new SecA inhibitor isolated from a fungus.
    Sugie Y; Inagaki S; Kato Y; Nishida H; Pang CH; Saito T; Sakemi S; Dib-Hajj F; Mueller JP; Sutcliffe J; Kojima Y
    J Antibiot (Tokyo); 2002 Jan; 55(1):25-9. PubMed ID: 11918061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA gyrase inhibitors: Progress and synthesis of potent compounds as antibacterial agents.
    Khan T; Sankhe K; Suvarna V; Sherje A; Patel K; Dravyakar B
    Biomed Pharmacother; 2018 Jul; 103():923-938. PubMed ID: 29710509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An optimised series of substituted N-phenylpyrrolamides as DNA gyrase B inhibitors.
    Tiz DB; Skok Ž; Durcik M; Tomašič T; Mašič LP; Ilaš J; Zega A; Draskovits G; Révész T; Nyerges Á; Pál C; Cruz CD; Tammela P; Žigon D; Kikelj D; Zidar N
    Eur J Med Chem; 2019 Apr; 167():269-290. PubMed ID: 30776691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of substituted oxadiazoles as a novel scaffold for DNA gyrase inhibitors.
    Jakopin Ž; Ilaš J; Barančoková M; Brvar M; Tammela P; Sollner Dolenc M; Tomašič T; Kikelj D
    Eur J Med Chem; 2017 Apr; 130():171-184. PubMed ID: 28246042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CJ-15,696 and its analogs, new furopyridine antibiotics from the fungus Cladobotryum varium: fermentation, isolation, structural elucidation, biotransformation and antibacterial activities.
    Sakemi S; Bordner J; DeCosta DL; Dekker KA; Hirai H; Inagaki T; Kim YJ; Kojima N; Sims JC; Sugie Y; Sugiura A; Sutcliffe JA; Tachikawa K; Truesdell SJ; Wong JW; Yoshikawa N; Kojima Y
    J Antibiot (Tokyo); 2002 Jan; 55(1):6-18. PubMed ID: 11918067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mode of action of closthioamide: the first member of the polythioamide class of bacterial DNA gyrase inhibitors.
    Chiriac AI; Kloss F; Krämer J; Vuong C; Hertweck C; Sahl HG
    J Antimicrob Chemother; 2015 Sep; 70(9):2576-88. PubMed ID: 26174721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Bacterial Topoisomerase Inhibitors with Potent Broad-Spectrum Activity against Drug-Resistant Bacteria.
    Charrier C; Salisbury AM; Savage VJ; Duffy T; Moyo E; Chaffer-Malam N; Ooi N; Newman R; Cheung J; Metzger R; McGarry D; Pichowicz M; Sigerson R; Cooper IR; Nelson G; Butler HS; Craighead M; Ratcliffe AJ; Best SA; Stokes NR
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug efficacy of novel 3-O-methoxy-4-halo disubstituted 5,7-dimethoxy chromans; evaluated via DNA gyrase inhibition, bacterial cell wall lesion and antibacterial prospective.
    Ponnusamy T; Alagumuthu M; Thamaraiselvi S
    Bioorg Med Chem; 2018 Jul; 26(12):3438-3452. PubMed ID: 29803359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of Benzothiazole Scaffold-Based DNA Gyrase B Inhibitors.
    Gjorgjieva M; Tomašič T; Barančokova M; Katsamakas S; Ilaš J; Tammela P; Peterlin Mašič L; Kikelj D
    J Med Chem; 2016 Oct; 59(19):8941-8954. PubMed ID: 27541007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The action of the bacterial toxin microcin B17. Insight into the cleavage-religation reaction of DNA gyrase.
    Pierrat OA; Maxwell A
    J Biol Chem; 2003 Sep; 278(37):35016-23. PubMed ID: 12829716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationship in two series of aminoalkyl substituted coumarin inhibitors of gyrase B.
    Laurin P; Ferroud D; Schio L; Klich M; Dupuis-Hamelin C; Mauvais P; Lassaigne P; Bonnefoy A; Musicki B
    Bioorg Med Chem Lett; 1999 Oct; 9(19):2875-80. PubMed ID: 10522710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LL-49F233alpha, a novel antibiotic produced by an unknown fungus: biological and mechanistic activities.
    Singh MP; Zaccardi J; Greenstein M
    J Antibiot (Tokyo); 1998 Dec; 51(12):1109-12. PubMed ID: 10048571
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro biological evaluation of novel broad-spectrum isothiazolone inhibitors of bacterial type II topoisomerases.
    Charrier C; Salisbury AM; Savage VJ; Moyo E; Forward H; Ooi N; Cheung J; Metzger R; McGarry D; Walker R; Cooper IR; Ratcliffe AJ; Stokes NR
    J Antimicrob Chemother; 2016 Oct; 71(10):2831-9. PubMed ID: 27353465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of 4,5,6,7-Tetrahydrobenzo[1,2-d]thiazoles as Novel DNA Gyrase Inhibitors Targeting the ATP-Binding Site.
    Tomašič T; Katsamakas S; Hodnik Ž; Ilaš J; Brvar M; Solmajer T; Montalvão S; Tammela P; Banjanac M; Ergović G; Anderluh M; Peterlin Mašič L; Kikelj D
    J Med Chem; 2015 Jul; 58(14):5501-21. PubMed ID: 26098163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual targeting of DNA gyrase and topoisomerase IV: target interactions of heteroaryl isothiazolones in Staphylococcus aureus.
    Cheng J; Thanassi JA; Thoma CL; Bradbury BJ; Deshpande M; Pucci MJ
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2445-53. PubMed ID: 17502409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Salmonella Typhimurium DNA gyrase as a target of quinolones.
    Kongsoi S; Yokoyama K; Suprasert A; Utrarachkij F; Nakajima C; Suthienkul O; Suzuki Y
    Drug Test Anal; 2015 Aug; 7(8):714-20. PubMed ID: 25381884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclothialidine and its congeners: a new class of DNA gyrase inhibitors.
    Goetschi E; Angehrn P; Gmuender H; Hebeisen P; Link H; Masciadri R; Nielsen J
    Pharmacol Ther; 1993 Nov; 60(2):367-80. PubMed ID: 8022866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.